Literature DB >> 29199261

TBX19 is overexpressed in colorectal cancer and associated with lymph node metastasis.

Jin Ando1, Motonobu Saito1, Jun-Ichi Imai2, Emi Ito2, Yuka Yanagisawa3, Reiko Honma3, Katsuharu Saito1, Kazunoshin Tachibana4, Tomoyuki Momma1, Shinji Ohki1, Tohru Ohtake4, Shinya Watanabe2, Satoshi Waguri5, Koji Kono1, Seiichi Takenoshita1.   

Abstract

The T-box 19 (TBX19) gene encodes a transcription factor characterized by a highly conserved DNA-binding motif (T-box). Recent studies have revealed that TBX19 has been identified as one of the genes activated by KRAS mutations, and is upregulated in colon adenoma. These results indicate that TBX19 may work as an oncogene in colorectal cancer (CRC). However, the expression and role of TBX19 have yet to be investigated. Here, we investigated TBX19 mRNA and protein expressions in colon cancer cells or surgically resected CRC. We found that TBX19 mRNA expression was significantly increased in tumorous tissues compared to that in non-tumorous tissues, and increased TBX19 mRNA expression was associated with positive lymph node metastasis in our cohort. The expression of TBX19 mRNA was not correlated with that of TBX19 protein in tissue sample taken from the CRC patients. Moreover, TBX19 showed positive staining even in the normal colonic tissues and the adjacent non-tumorous tissues. These results suggest that the expression of TBX19 protein is not correlated with the expression of TBX19 mRNA. In addition, our results promote further investigations into the impact of TBX19 upregulation on colorectal carcinogenesis, as well as the underlying mechanisms.

Entities:  

Keywords:  TBX19; colorectal cancer; cytoplasmic granular signal; diagnostic biomarker; lymph node metastasis

Mesh:

Substances:

Year:  2017        PMID: 29199261      PMCID: PMC5792498          DOI: 10.5387/fms.2017-08

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Tbx19, a tissue-selective regulator of POMC gene expression.

Authors:  J Liu; C Lin; A Gleiberman; K A Ohgi; T Herman; H P Huang; M J Tsai; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 3.  KRAS as a Therapeutic Target.

Authors:  Frank McCormick
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

4.  Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.

Authors:  Keith W Vance; Suzanne Carreira; Gerald Brosch; Colin R Goding
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

Review 5.  T-box genes in human disorders.

Authors:  Elizabeth A Packham; J David Brook
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

Review 6.  The T-box transcription factor Tbx2: its role in development and possible implication in cancer.

Authors:  Amaal Abrahams; M Iqbal Parker; Sharon Prince
Journal:  IUBMB Life       Date:  2010-02       Impact factor: 3.885

Review 7.  The role of Tbx2 and Tbx3 in mammary development and tumorigenesis.

Authors:  Matthew Rowley; Erin Grothey; Fergus J Couch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-04       Impact factor: 2.673

Review 8.  Colorectal cancer.

Authors:  Hermann Brenner; Matthias Kloor; Christian Peter Pox
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

9.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

10.  Mutational landscape and significance across 12 major cancer types.

Authors:  Cyriac Kandoth; Michael D McLellan; Fabio Vandin; Kai Ye; Beifang Niu; Charles Lu; Mingchao Xie; Qunyuan Zhang; Joshua F McMichael; Matthew A Wyczalkowski; Mark D M Leiserson; Christopher A Miller; John S Welch; Matthew J Walter; Michael C Wendl; Timothy J Ley; Richard K Wilson; Benjamin J Raphael; Li Ding
Journal:  Nature       Date:  2013-10-17       Impact factor: 49.962

View more
  3 in total

1.  T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.

Authors:  Xiaoyu Ji; Xiaoping Chen; Bixiang Zhang; Meng Xie; Tongyue Zhang; Xiangyuan Luo; Danfei Liu; Yangyang Feng; Yijun Wang; Mengyu Sun; Congxin Li; Wenjie Huang; Limin Xia
Journal:  Oncogene       Date:  2022-02-26       Impact factor: 9.867

2.  Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma.

Authors:  FeiYan Ai; Wenhao Wang; Shaojun Liu; Decai Zhang; Zhenyu Yang; Fen Liu
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

3.  Genomic and regulatory characteristics of significant transcription factors in colorectal cancer metastasis.

Authors:  Bin Zhou; Rui Guo
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.